Evidence map›Paper›PMID 23970701›Full record

Observational studyInternational journal of STD & AIDS2013

Neurocognitive impairment in HIV-infected individuals with previous syphilis.

C M Marra, R Deutsch, A C Collier, S Morgello, S Letendre, D Clifford, B Gelman, J McArthur, J A McCutchan, D M Simpson and 3 more

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in International journal of STD & AIDS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Management of Adult Syphilis: Key Questions to Inform the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Emerging Role of Nef in the Development of HIV Associated Neurological Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Neurosyphilis During Acute HIV Infection: A CNS Immunologic and Virologic Characterization.Journal of acquired immune deficiency syndromes (1999) · 2019
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

C M MarraDepartment of Neurology, University of Washington, Seattle, WA, USA. cmarra@u.washington.edu
R Deutsch
A C Collier
S Morgello
S Letendre
D Clifford
B Gelman
J McArthur
J A McCutchan
D M Simpson
N A Duarte
R K Heaton
I Grant
University of California, San Diego · USIcahn School of Medicine at Mount Sinai · USUniversity of Washington · USJohns Hopkins University · USWashington University in St. Louis · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVID J MOORE · 2001 to 2026
$50.4M
PERSISTENCE OF CNS T PALLIDUM IN HIV INFECTIONR01NS034235 · NINDS · UNIVERSITY OF WASHINGTON · PI MARRA, CHRISTINA M · 1996 to 2018
$7.0M
Midcareer Investigator Award in Patient-Oriented NeuroAIDS ResearchK24MH097673 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LETENDRE, SCOTT L · 2013 to 2017
$917k
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH /CHARTER/ -278022005-278022005N01MH022005 · NIMH · UNIVERSITY OF CA -SAN DIEGO · PI GRANT, IGOR · 2003 to 2006
–
NIMH NIH HHS HHSN271201000036CNIMH NIH HHS K24 MH097673NIMH NIH HHS N01 MH022005NIMH NIH HHS P30 MH062512NINDS NIH HHS R01 NS034235NINDS NIH HHS R01 NS34235
6 · The paper itself

Abstract

Cognitive impairment is common in HIV-infected individuals, as is syphilis. Treponema pallidum, the bacterium that causes syphilis, invades the central nervous system early in disease. We hypothesized that HIV-infected patients with a history of syphilis or neurosyphilis would have more cognitive impairment than HIV-infected individuals without these infections. Eighty-two of 1574 enrollees in CHARTER, a prospective, observational study, had reactive serum rapid plasma reagin (RPR) tests. They were matched to 84 controls with non-reactive RPR by age, gender, ethnicity and HIV risk factor. Participants underwent comprehensive neuropsychological (NP) evaluations. RPR results were confirmed and serum fluorescent treponemal antibody absorption (FTA-ABS) test reactivity determined at a central laboratory. Sera from 101 of 166 participants were FTA-ABS reactive, indicating past or current syphilis. Among the 136 individuals without confounding conditions, compared with patients who had never had syphilis, those with prior syphilis had a greater number of impaired NP test domains (1.90 SD [1.77] versus 1.25 [1.52], P = 0.03), a higher global deficit score (0.47 [0.46] versus 0.31 [0.33], P = 0.03), and more were impaired in the NP learning domain (36 [42.9%] of 84 versus 13 [25.0%] of 52, P = 0.04). These effects of prior syphilis remained after controlling for education and premorbid intelligence.

Indexed as

AdultCase-Control StudiesCognition DisordersFemaleFluorescent Treponemal Antibody-Absorption TestHIV InfectionsHumansMaleMiddle AgedNeuropsychological TestsNeurosyphilisProspective StudiesSyphilisSyphilis SerodiagnosisTreponema pallidumAIDScentral nervous systemHIVneurocognitive impairmentneurosyphilissexually transmitted infectionsyphilisTreponema pallidum

Identifiers

PMID23970701
PMCPMC4560461
OpenAlexW2003741326

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.